Cancer cells have developed several mechanisms to inhibit p73 expression, ranging from the hypermethylation of the p73 promoter in some leukemias and lymphomas [28,29] to the modulation of the ratio between the pro- and anti-apoptotic p73 isoforms in various other tumors [17,118,130]. The gene discussed is TP73; the disease is lymphoma.